- জেনেরিক নাম
- Ibandronic Acid
- শক্তি
- 150 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Radiant Pharmaceuticals Ltd.
৳ ২৪৫৭.৩৭ ৳ ২৫০৭.৫২ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
Bonova হলো Ibandronic Acid-এর একটি ব্র্যান্ড, শক্তি ১৫০ mg, ট্যাবলেট আকারে। এটি তৈরি করে Radiant Pharmaceuticals Ltd। Bonova-এর প্রতি ইউনিটের দাম ২৫০৭.৫২ টাকা। Bonova-এর সাথে Ibandronic Acid-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Ibandronic Acid-এর ১৩টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ১০টি। সবচেয়ে কম দাম Bondrix 150 mg Tablet-এর, প্রতি ইউনিট ৳ ৪০০.০০।
Bonova 150 mg tablet is a bisphosphonate preparation made by Radiant Pharmaceuticals Ltd. Its active ingredient is ibandronic acid, which works by slowing the breakdown of bone. It is prescribed for postmenopausal osteoporosis, where the doctor may confirm low bone mass with or without a previous osteoporotic fracture. The tablet comes in a kit pack. Ibandronic acid is a potent inhibitor of bone resorption. Treatment aims to reduce the risk of fractures. The doctor confirms the diagnosis and decides whether this medicine is suitable. Do not start or stop it without medical advice.
Bonova is used to treat osteoporosis in women after menopause and to reduce the risk of fractures. The diagnosis may be based on low bone mass and a past osteoporotic fracture, or on low bone mass alone when no fracture has been documented. It is not a general tonic for bone strength and should only be taken when a doctor has diagnosed osteoporosis and prescribed it for you.
Take Bonova exactly as your doctor tells you, and do not change the dose or course yourself. Swallow the tablet whole with a full glass of plain water while sitting or standing upright. Do not take it with any drink other than plain water, and do not lie down afterwards, as your doctor advises. The doctor will tell you when in the day to take it and how to fit it around food, drink and other medicines. Ask your pharmacist if you are unsure.
Common side effects of ibandronic acid include indigestion, nausea, diarrhoea, stomach pain, muscle aches, headache and dizziness. Tell your doctor or pharmacist if any of these bother you or do not settle. Some people may have other reactions. Seek medical advice promptly if you have severe stomach or chest symptoms, trouble swallowing, or any unusual problem after taking it. Do not treat side effects with other medicines on your own without asking a healthcare professional first.
Do not take Bonova if you are allergic to ibandronic acid or any ingredient of the tablet. It is not for people with uncorrected low calcium levels or with certain oesophageal problems that slow the passage of food, or for anyone who cannot sit or stand upright for the period the doctor requires. Tell your doctor about stomach or swallowing problems before starting. Low calcium and other mineral problems should be treated first, and calcium and vitamin D intake matters. Bonova should not be used in pregnancy; breastfeeding women should ask the doctor before use. Anyone who is pregnant, may be pregnant or is breastfeeding should speak to the doctor first.
The listed price is ৳ ২৫০৭.৫২. Prices can change, so check the current price on the product listing or ask your pharmacy. Your pharmacist can also explain what the kit contains and any dispensing charges that may apply.
Calcium supplements, antacids and some oral medicines containing aluminium, magnesium or iron can interfere with how ibandronic acid is absorbed. The doctor will tell you how to space these apart from Bonova. Always tell your doctor and pharmacist about every medicine, supplement and vitamin you take.
Bonova is a bisphosphonate preparation containing ibandronic acid. It is used to treat postmenopausal osteoporosis and to reduce the risk of fractures. The doctor confirms the diagnosis before prescribing it. It is not a painkiller and is not meant for general bone strengthening without a diagnosis.
Bonova should not be used during pregnancy. If you are breastfeeding, ask your doctor before using it, because a decision is needed on whether it is appropriate for you. Tell your doctor if you are pregnant, think you may be pregnant, or are planning a pregnancy.
৳ ২৪৫৭.৩৭ ৳ ২৫০৭.৫২ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ibandronic acid is indicated for the treatment of postmenopausal osteoporosis, to reduce the risk of fractures.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The pharmacodynamic action of ibandronic acid is inhibition of bone resorption. In vivo, ibandronic acid prevents experimentally induced bone destruction caused by cessation of gonadal function, retinoids, tumors or tumor extracts. In young (fast growing) rats, the endogenous bone resorption is also inhibited, leading to increased bone mass compared with untreated animals. Animal models confirm that ibandronic acid is a highly potent inhibitor of osteoclastic activity. In growing rats, there was no evidence of impaired mineralization even at doses greater than 5,000 times the dose required for osteoporosis treatment. The high potency and therapeutic margin of ibandronic acid allows for more flexible dosing regimens and intermittent treatment with long drug-free intervals at comparatively low doses.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The recommended dose of Ibandronic acid for treatment is one 150 mg film-coated tablet once a month. The tablet should preferably be taken on the same date each month. Ibandronic acid should be taken 60 minutes before the first food or drink (other than water) of the day or any other oral medication or supplementation (including calcium):এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
It is likely that calcium supplements, antacids and some oral medications containing multivalent cations (such as aluminium, magnesium, iron) are likely to interfere with the absorption of Ibandronic Acid. Therefore, patients must wait 60 minutes after taking Ibandronic Acid before taking other oral medications. Pharmacokinetic interaction studies in postmenopausal women have demonstrated the absence of any interaction potential with tamoxifen or hormone replacement therapy (estrogen). No interaction was observed when co-administered with melphalan/prednisolone in patients with multiple myeloma. In healthy male volunteers and postmenopausal women, i.v. ranitidine caused an increase in ibandronic acid bioavailability of about 20 %, probably as a result of reduced gastric acidity. However, since this increase is within the normal range of the bioavailability of ibandronic acid, no dosage adjustment is required when Ibandronic Acid is administered with H2-antagonists or other drugs which increase gastric pH.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ibandronic Acid is contraindicated in patients with known hypersensitivity to ibandronic acid or to any of the excipients. Ibandronic Acid is contraindicated in patients with uncorrected hypocalcemia. As with all bisphosphonates indicated in the treatment of osteoporosis, pre-existing hypocalcemia needs to be corrected before initiating therapy with Ibandronic Acid. As with several bisphosphonates, Ibandronic Acid is contraindicated in patients with abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia. Ibandronic Acid is contraindicated in patients who are unable to stand or sit upright for at least 60 minutes.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The main side effects of ibandronic acid are dyspepsia, nausea, diarrhea, abdominal pain, muscle aches, headaches, dizziness.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy: Ibandronic Acid should not be used during pregnancy. There was no evidence for a direct fetal toxic or teratogenic effect of ibandronic acid in daily orally treated rats and rabbits and there were no adverse effects on the development in F1 offspring in rats. Adverse effects of ibandronic acid in reproductive toxicity studies in the rat were those observed with bisphosphonates as a class. They include a decreased number of implantation sites, interference with natural delivery (dystocia), and an increase in visceral variations (renal pelvis ureter syndrome). Specific studies for the monthly regimen have not been performed. There is no clinical experience with Ibandronic Acid in pregnant women.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypocalcemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Ibandronic Acid therapy. Adequate intake of calcium and vitamin D is important in all patients. Orally administered bisphosphonates may cause local irritation of the upper gastrointestinal mucosa. Because of these possible irritant effects and a potential for worsening of the underlying disease, caution should be used when Ibandronic Acid is given to patients with active upper gastrointestinal problems (e.g. known Barrett’s esophagus, dysphagia, other esophageal diseases, gastritis, duodenitis or ulcers). Adverse experiences such as esophagitis, esophageal ulcers and esophageal erosions, in some cases severe and requiring hospitalization, rarely with bleeding or followed by esophageal stricture or perforation, have been reported in patients receiving treatment with oral bisphosphonates. The risk of severe esophageal adverse experiences appears to be greater in patients who do not comply with the dosing instruction and/or who continue to take oral bisphosphonates after developing symptoms suggestive of esophageal irritation. Patients should pay particular attention and be able to comply with the dosing instructions.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
No specific information is available on the treatment of overdosage with ibandronic acid. However, oral overdosage may result in upper gastrointestinal adverse events, such as upset stomach, heartburn, esophagitis, gastritis, or ulcer. Milk or antacids should be given to bind ibandronic acid. Owing to the risk of esophageal irritation, vomiting should not be induced and the patient should remain fully upright.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।